Short-Term Sitagliptin-Metformin Therapy Is More Effective Than Metformin Or Placebo In Prior Gestational Diabetic Women With Impaired Glucose Regulation

This publication has 27 references indexed in Scilit:

• Dipeptidyl peptidase IV inhibitors: a new paradigm in type 2 diabetes treatment.
  Current Drug Targets, 2014
• Prevention of Diabetes in Women with a History of Gestational Diabetes: Effects of Metformin and Lifestyle Interventions
  The Journal of Clinical Endocrinology & Metabolism, 2008
• The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
  The Lancet, 2006
• Pharmacological Treatment of Insulin Resistance at Two Different Stages in the Evolution of Type 2 Diabetes: Impact on Glucose Tolerance and β-Cell Function
  The Journal of Clinical Endocrinology & Metabolism, 2004
• Minireview: Glucagon-Like Peptides Regulate Cell Proliferation and Apoptosis in the Pancreas, Gut, and Central Nervous System
  Endocrinology, 2004
• Gestational Diabetes and Insulin Resistance: Role in Short- and Long-Term Implications for Mother and Fetus
  The Journal of Nutrition, 2003
• Preservation of Pancreatic β-Cell Function and Prevention of Type 2 Diabetes by Pharmacological Treatment of Insulin Resistance in High-Risk Hispanic Women
  Diabetes, 2002
• Effects of Glucagon-Like Peptide 1 on Counterregulatory Hormone Responses, Cognitive Functions, and Insulin Secretion during Hyperinsulinemic, Stepped Hypoglycemic Clamp Experiments in Healthy Volunteers
  The Journal of Clinical Endocrinology & Metabolism, 2002
• Pancreatic B-Cell Defects in Gestational Diabetes: Implications for the Pathogenesis and Prevention of Type 2 Diabetes
  The Journal of Clinical Endocrinology & Metabolism, 2001
• Abnormalities of Glucose Tolerance Following Gestational Diabetes
  QJM: An International Journal of Medicine, 1990